A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes

Mike G. Martin, Richard A. Walgren, Elizabeth Procknow, Geoffrey L. Uy, Keith Stockerl-Goldstein, Amanda F. Cashen, Peter Westervelt, Camille N. Abboud, Frederieke Kreisel, Kristan Augustin, John F. DiPersio, Ravi Vij

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science